These new tools are designed to push the frontiers of scientific research, particularly in understanding complex diseases such as Alzheimer’s and cancer, and to advance the field of precision medicine.
The funding round attracted participation from prominent investors such as ARK Invest, DFJ Growth, Founders Fund, G42, Human Capital, Lightspeed, QIA, Sequoia Capital, Thrive Capital, Valor Equity Partners, and Vy Capital, among others.
This expansion is set to create 100 new jobs, reinforcing the company’s commitment to meeting the growing demand for advanced pharmaceutical components.
The platform supports instant appointment booking with verified doctors across a wide range of specialties, including Dentistry, Dermatology, Gynecology, General Practice, ENT, Physiotherapy, Psychiatry, and more.
Developed in collaboration with two leading pharmaceutical partners, SynTiso aims to address some of the most pressing challenges facing drug manufacturers today.
The materials used to build the model were selected from the Center’s extensive in-house database of tissue-mimicking substances, which are specially designed for radiology applications.
This upgrade includes a 128-slice CT scanner, a digital X-ray unit, and an advanced mammography system.
This study aims to evaluate whether a new ultra-low X-ray dose technology can significantly reduce radiation exposure during coronary artery procedures without compromising image quality or procedural performance.
Syntegon’s order intake rose by 11% to €1.8 billion (US$1.9 billion), while revenues increased 7% to €1.6 billion (US$$1.7 billion).
MEDEXPO Kenya is recognized as the region’s premier trade exhibition for medical manufacturing products, equipment, machinery, services, and solutions.